UK Multiple Myeloma Patients Allowed Early Access To Sanofi’s Isatuximab
The UK scheme allows patients with early access to promising new unlicensed medicines when there is a clear unmet medical need.
The UK scheme allows patients with early access to promising new unlicensed medicines when there is a clear unmet medical need.